Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.
Gottlieb GS, Smith RA, Dia Badiane NM, Ba S, Hawes SE, Toure M, Starling AK, Traore F, Sall F, Cherne SL, Stern J, Wong KG, Lu P, Kim M, Raugi DN, Lam A, Mullins JI, Kiviat NB; Papa Salif Sow for the UW-Dakar HIV-2 Study Group. Gottlieb GS, et al. Among authors: mullins ji. PLoS One. 2011;6(7):e22204. doi: 10.1371/journal.pone.0022204. Epub 2011 Jul 12. PLoS One. 2011. PMID: 21765953 Free PMC article.
Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy.
Raugi DN, Smith RA, Ba S, Toure M, Traore F, Sall F, Pan C, Blankenship L, Montano A, Olson J, Dia Badiane NM, Mullins JI, Kiviat NB, Hawes SE, Sow PS, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group. Raugi DN, et al. Among authors: mullins ji. Antimicrob Agents Chemother. 2013 Jun;57(6):2751-60. doi: 10.1128/AAC.00405-13. Epub 2013 Apr 9. Antimicrob Agents Chemother. 2013. PMID: 23571535 Free PMC article.
Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.
Gottlieb GS, Badiane NM, Hawes SE, Fortes L, Toure M, Ndour CT, Starling AK, Traore F, Sall F, Wong KG, Cherne SL, Anderson DJ, Dye SA, Smith RA, Mullins JI, Kiviat NB, Sow PS; University of Washington-Dakar HIV-2 Study Group. Gottlieb GS, et al. Among authors: mullins ji. Clin Infect Dis. 2009 Feb 15;48(4):476-83. doi: 10.1086/596504. Clin Infect Dis. 2009. PMID: 19143530 Free PMC article.
Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens.
Smith RA, Raugi DN, Pan C, Coyne M, Hernandez A, Church B, Parker K, Mullins JI, Sow PS, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group. Smith RA, et al. Among authors: mullins ji. PLoS One. 2012;7(9):e45372. doi: 10.1371/journal.pone.0045372. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028968 Free PMC article.
Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
Gottlieb GS, Hawes SE, Nickle DC, Herbeck JT, Kiviat NB, Mullins JI, Sow PS. Gottlieb GS, et al. Among authors: mullins ji. JAMA. 2007 Feb 28;297(8):805; author reply 806-7. doi: 10.1001/jama.297.8.805-a. JAMA. 2007. PMID: 17327518 No abstract available.
398 results